Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2020
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,059
-14.01%
|
$734,679
$181.02 P/Share
|
|
Dec 14
2020
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
400
-1.34%
|
$71,200
$178.44 P/Share
|
|
Dec 01
2020
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
800
-2.61%
|
$142,400
$178.6 P/Share
|
|
Dec 01
2020
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,188
-7.85%
|
$573,840
$180.0 P/Share
|
|
Dec 01
2020
|
John W. Pietrowicz Sr MD Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.58%
|
$900,000
$180.0 P/Share
|
|
Dec 01
2020
|
John W. Pietrowicz Sr MD Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.28%
|
$270,000
$54.37 P/Share
|
|
Nov 02
2020
|
Ken Vroman Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
4,541
-31.49%
|
$690,232
$152.63 P/Share
|